Rapporto sull’analisi delle dimensioni del mercato e delle quote del mercato dei dispositivi per biopsia | Previsioni 2031

  • Report Code : TIPHE100001402
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 196
Buy Now

Si prevede che il mercato dei dispositivi per biopsia raggiungerà i 3.584,20 milioni di dollari entro il 2027 rispetto ai 2.230,86 milioni di dollari del 2019. Si prevede che il mercato crescerà a un CAGR del 6,2% dal 2020 al 2027.

  ;

Una biopsia è un esame medico generalmente eseguito da chirurghi, radiologi interventisti o cardiologi interventisti per estrarre cellule o tessuti campione; questi esami aiutano nell'identificazione e nella determinazione delle condizioni della malattia. Il tessuto viene generalmente osservato al microscopio dai patologi e può anche essere esaminato chimicamente. Le biopsie vengono eseguite più comunemente per identificare condizioni cancerose e infiammatorie.

Regioni redditizie per il mercato dei dispositivi per biopsia

Approfondimenti di mercato

Aumento dei tassi di cancro

La biopsia si riferisce a un test diagnostico che aiuta a identificare vari tipi di cancro e anomalie non cancerose nel corpo umano. È probabile che la crescente prevalenza del cancro tra la popolazione aumenti la crescita del mercato dei dispositivi per biopsia in tutto il mondo. Ad esempio, in Canada, il cancro è la principale causa di morte tra la popolazione, ed è la seconda causa dopo le malattie cardiache negli Stati Uniti. Secondo l’American Cancer Society, nel 2018 sono stati registrati circa 1,9 milioni di nuovi casi di cancro e 693.000 decessi per cancro. I tumori della prostata sono i tumori più comunemente diagnosticati tra i maschi del Nord America; tuttavia, i tumori al seno rimangono predominanti nelle donne. Inoltre, il cancro ai polmoni rimane la causa di morte più comune in entrambi i sessi. Si stima che il numero di nuovi casi di incidenza di cancro sia di 439,2 ogni 100.000 uomini e donne all'anno.

Secondo il profilo sanitario nazionale, i casi di tumori comuni, compresi i tumori cervicali, orali e mammari, sono aumentati del 324% in India dal 2017 al 2018. Inoltre, il numero totale di pazienti visitati in cliniche per malattie non trasmissibili (NCD) è raddoppiato tra il 2017 e il 2018, raggiungendo i 35 milioni e 66 milioni rispettivamente. Il rapido cambiamento nello stile di vita e nel consumo di alcol e prodotti del tabacco è tra i fattori principali che aumentano l'incidenza del cancro nella popolazione.

BD, Qiagen, F.Hoffmann La-Roche Ltd., Hologic e Boston Scientific Corporation sono tra le principali aziende produttrici di dispositivi e accessori per biopsia per la diagnosi del cancro e di altre malattie. Pertanto, si prevede che la crescente prevalenza del cancro nel mondo guiderà la crescita del mercato globale dei dispositivi per biopsia durante il periodo di previsione.

Approfondimenti di mercato basati sul prodotto

Il mercato dei dispositivi per biopsia è segmentato in base al prodotto in biopsia con ago, vassoi procedurali, fili di localizzazione e altri. Nel 2019, il segmento della biopsia con ago rappresentava la quota maggiore del mercato globale dei dispositivi per biopsia. La crescita del mercato per questo segmento è attribuita alla crescente adozione di procedure di biopsia con ago grazie alla loro elevata precisione e con lesioni minime. Inoltre, è probabile che il segmento testimonierà anche il CAGR più rapido del mercato durante gli anni previsti.

Mercato globale dei dispositivi per biopsia, per prodotto: 2019 e 2027

Approfondimenti di mercato basati sulla tecnologia

Sulla base della tecnologia, il mercato globale dei dispositivi per biopsia è segmentato in TAC e guida ecografica biopsia, biopsia stereotassica, risonanza magnetica e altri. Nel 2019, il segmento della biopsia ecoguidata deteneva la quota maggiore del mercato. Tuttavia, si prevede che il segmento delle scansioni TC registrerà un CAGR significativo durante il periodo di previsione.

Approfondimenti di mercato basati sull'applicazione

La biopsia globale Il mercato dei dispositivi, in base all'applicazione, è segmentato in biopsia polmonare, biopsia renale, biopsia epatica, biopsia mammaria e altri. Nel 2019, il segmento della biopsia mammaria deteneva la quota maggiore del mercato e si prevede che registrerà il CAGR più elevato anche nel periodo 2020-2027.

Approfondimenti strategici

Partnership, lancio di prodotti e acquisizioni sono le strategie più comunemente adottate dalle aziende per espandere la propria presenza in tutto il mondo e soddisfare la crescente domanda ampliando il proprio portafoglio di prodotti. Ad esempio, nel dicembre 2017, BD, fornitore leader di tecnologia medica, ha acquisito CR Bard, Inc. Questa acquisizione ha creato un nuovo leader del settore sanitario nel mercato globale. Bard, con il suo solido portafoglio di prodotti e la sua pipeline di innovazioni, ha ampliato la portata delle opportunità nel settore dei dispositivi medici in rapida crescita nei mercati globali.

Mercato globale dei dispositivi per biopsia - ; Per prodotto

  • Biopsia con ago
    • Dispositivi per biopsia centrale
    • Aghi per biopsia per aspirazione
    • Dispositivi per biopsia assistita da vuoto (VAB)
  • Fili di localizzazione
  • Vassoi procedurali
  • Altro

Mercato globale dei dispositivi per biopsia &ndash ; Per tecnologia

  • Scansione TC
  • Biopsia guidata da ultrasuoni
  • Biopsia guidata stereotassica
  • Biopsia guidata da MRI
  • Altri

Mercato globale dei dispositivi per biopsia: Per applicazione

  • Biopsia polmonare
  • Biopsia renale
  • Biopsia epatica
  • Biopsia mammaria
  • Altro< /li>

Mercato dei dispositivi per biopsia: Per area geografica

  • Nord America
    • Stati Uniti
    • Canada
    • Messico
  • < li>Europa
    • Francia
    • Germania
    • Italia
    • Regno Unito
    • Spagna
    • Svezia
    • Danimarca
    • Norvegia
  • Asia Pacifico
    • Cina
    • India
    • Corea del Sud
    • Giappone
    • Australia
  • Medio Oriente e Africa
    • Sudafrica
    • Arabia Saudita
    • Emirati Arabi Uniti
  • America centrale e meridionale
    • Brasile
    • Argentina

Profili aziendali

  • BD
  • B . Braun Melsungen AG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Danaher
  • Fujifilm Corporation
  • Hologic, Inc.
  • Medtronic
  • Argon Medical Devices
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is biopsy?

A biopsy is a medical examination generally implemented by a surgeon, interventional radiologist, or an interventional cardiologist to extract sample cells or tissues and helps in identification, existence of a disease. The tissue is generally observed under a microscope by a pathologist, and can also be examined chemically. Biopsies are most commonly performed to identify cancerous and inflammatory conditions.

What are the driving factors for the biopsy devices market across the globe?

The biopsy devices market is anticipated to grow with a significant rate in the coming years, owing to factors such as rising patient awareness on cancer and the improvement in biopsy procedures. Increasing incidences of cancer such as breast, prostate, & lung, and rapid technological advancements, initiatives to spread awareness about cancer are expected to offer growth opportunities for the players operating in the market.

What is the regional analysis in terms of biopsy devices market?

North America is the largest market for the biopsy devices market. The factors that are responsible for the dominance of the region include rising government support through the for cancer care in the US and Canada, rising incidence of cancer patients leading to increased demand in kits and products used for testing and diagnosis, increasing awareness among general populace regarding advantages of early testing of diseases and consistent development and launch of novel biopsy products in the market through advanced and extensive research and development. The biopsy devices market in the US is expected to be the largest in the North American region. The growth of the market in the country is attributed to the active participation and support of the government towards the cancer care. Besides this, the increase in the number of cancer population and the technological developments in biopsy devices are likely to help in the growth of the market.

The List of Companies - Biopsy Devices Market

  1. BD
  2. B. Braun Melsungen AG
  3. Boston Scientific Corporation
  4. Cardinal Health, Inc.
  5. Cook Medical LLC
  6. Danaher
  7. Fujifilm Corporation
  8. Hologic, Inc.
  9. Medtronic
  10. Argon Medical Devices

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports